Recent investigations have implicated NOD2 in the progression of colorectal, breast, lung, endometrial, and cervical cancers, correlating with enhanced tumor invasion, proliferation, and poor patient survival [9,10,11,12,13]. This evidence concerns the gene NOD2 and neoplasm.